# EDGAR Filing Document

**Accession Number:** 0000937966
**File Stem:** 0000937966-23-000003
**Filing Date:** 2023-1
**Character Count:** 66641
**Document Hash:** 9f381ba4d8c799ebd23e038f50d8dfce
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000937966-23-000003.hdr.sgml**: 20230125

**ACCESSION NUMBER**: 0000937966-23-000003

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 29

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230125

**DATE AS OF CHANGE**: 20230125

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ASML HOLDING NV
- **CENTRAL INDEX KEY:** 0000937966
- **STANDARD INDUSTRIAL CLASSIFICATION:** SPECIAL INDUSTRY MACHINERY, NEC [3559]
- **IRS NUMBER:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33463
- **FILM NUMBER:** 23549627

**BUSINESS ADDRESS:**
- **STREET 1:** DE RUN 6501
- **CITY:** DR VELDHOVEN
- **STATE:** P7
- **ZIP:** 5504
- **BUSINESS PHONE:** 31402683000

**MAIL ADDRESS:**
- **STREET 1:** P.O. BOX 324
- **CITY:** AH VELDHOVEN
- **STATE:** P7
- **ZIP:** 5500

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ASM LITHOGRAPHY HOLDING NV
- **DATE OF NAME CHANGE:** 19950215

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549** <br>______________________

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**For January 25, 2023**

**Commission File Number 001-33463**

______________________

**ASML Holding N.V.**

De Run 6501

5504 DR Veldhoven

The Netherlands

(*Address of principal executive offices*)

______________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ⌧ Form 40-F ◻

Indicate by check mark if the registrant is submitting the Form 6-K on paper as permitted by Regulation S-T Rule 101(b)(1): ◻

Indicate by check mark if the registrant is submitting the Form 6-K on paper as permitted by Regulation S-T Rule 101(b)(7): ◻

EXHIBITS 99.1 AND 99.3 TO THIS REPORT ON FORM 6-K ARE INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-116337), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-126340), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-136362), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-141125), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-142254), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-144356), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-147128), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-153277), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-162439), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-170034), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-188938), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-190023), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-192951), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-203390), THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-219442) AND THE REGISTRATION STATEMENT ON FORM S-8 (FILE NO. 333-227464) OF ASML HOLDING N.V. AND IN THE OUTSTANDING PROSPECTUSES CONTAINED IN SUCH REGISTRATION STATEMENTS.

------

**<u>Exhibits</u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;** ![logo6ka.jpg](logo6ka.jpg)

99.1&nbsp;&nbsp;&nbsp;&nbsp;"ASML reports €21.2 billion net sales and €5.6 billion net income in 2022. Despite challenging environment, continued strong sales growth expected in 2023.", press release dated January 25, 2023

99.2&nbsp;&nbsp;&nbsp;&nbsp;"ASML reports €21.2 billion net sales and €5.6 billion net income in 2022. Despite challenging environment, continued strong sales growth expected in 2023.", presentation dated January 25, 2023

99.3&nbsp;&nbsp;&nbsp;&nbsp;Summary US GAAP Consolidated Financial Statements

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

**&nbsp;&nbsp;&nbsp;&nbsp;**ASML HOLDING N.V. (Registrant)

Date: January 25, 2023&nbsp;&nbsp;&nbsp;&nbsp;By:&nbsp;&nbsp;&nbsp;&nbsp;/<u>s/ Peter T.F.M. Wennink</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Peter T.F.M. Wennink

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer

## Exhibit 99.1

**Exhibit 99.1**

ASML reports €21.2 billion net sales and €5.6 billion net income in 2022

**Despite challenging environment, continued strong sales growth expected in 2023** 

VELDHOVEN, the Netherlands, January 25, 2023 – today ASML Holding NV (ASML) has published its 2022 fourth-quarter and full-year results.

• Q4 net sales of €6.4 billion, gross margin of 51.5%, net income of €1.8 billion

• Quarterly net bookings in Q4 of €6.3 billion<sup>2</sup> of which €3.4 billion is EUV

• 2022 net sales of €21.2 billion, gross margin of 50.5%, net income of €5.6 billion

• ASML expects 2023 net sales to grow over 25% compared to 2022

• ASML expects Q1 2023 net sales between €6.1 billion and €6.5 billion and a gross margin between 49% and 50%

• The value of fast shipments\* in 2022 leading to delayed revenue recognition into 2023 is around €3.1 billion

• ASML intends to declare a total dividend for the year 2022 of €5.80 per ordinary share; a 5.5% increase compared to 2021

(\*) A fast shipment process skips some of the testing in our factory. Final testing and formal acceptance then takes place at the customer site. This leads to a deferral of revenue recognition for those shipments until formal customer acceptance, but does provide our customers with earlier access to wafer output capacity.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(Figures in millions of euros unless otherwise indicated)** | **Q3 2022** | **Q4 2022** | **FY 2021** | **FY 2022** |
| Net sales | 5778 | **6430** | 18611 | **21173** |
| ...of which Installed Base Management sales <sup>1</sup> | 1524 | **1682** | 4958 | **5743** |
| New lithography systems sold (units) | 80 | **95** | 286 | **317** |
| Used lithography systems sold (units) | 6 | **11** | 23 | **28** |
| Net bookings <sup>2</sup> | 8920 | **6316** | 26240 | **30674** |
| Gross profit | 2994 | **3311** | 9809 | **10700** |
| Gross margin (%) | 51.8 | **51.5** | 52.7 | **50.5** |
| Net income | 1701 | **1817** | 5883 | **5624** |
| EPS (basic; in euros) | 4.29 | **4.60** | 14.36 | **14.14** |
| End-quarter cash and cash equivalents and short-term investments | 3363 | **7376** | 7590 | **7376** |

---

(1) Installed Base Management sales equals our net service and field option sales

(2) Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.

Numbers have been rounded for readers' convenience. A complete summary of US GAAP Consolidated Statements of Operations is published on www.asml.com

**CEO statement and outlook**

"Our fourth-quarter net sales came in around the midpoint of our guidance at €6.4 billion. The gross margin of 51.5% was above our guidance due to additional upgrades and insurance settlement for last year's ASML Berlin fire.

"For ASML, 2022 was another strong year ending with total net sales for the year of €21.2 billion, gross margin of 50.5% and a record backlog at the end of 2022 of €40.4 billion.

"We continue to see uncertainty in the market caused by inflation, rising interest rates, risk of recession and geopolitical developments related to export controls. However, our customers indicate that they expect the market to rebound in the second half of the year. Considering our order lead times and the strategic nature of lithography investments, demand for our systems therefore remains strong.

------

"For 2023, ASML expects continued strong growth with a net sales increase of more than 25% and a slight improvement in gross margin, relative to 2022. We expect first-quarter net sales between €6.1 billion and €6.5 billion with a gross margin between 49% and 50%. ASML expects R&D costs of around €965 million and SG&A costs of around €285 million," said ASML President and Chief Executive Officer Peter Wennink.

**Update share buyback program and dividend proposal**

In the fourth quarter we purchased around €300 million worth of shares under the previous, completed share buyback program and the current 2022-2025 program.

ASML intends to declare a total dividend for the year 2022 of €5.80 per ordinary share, which is a 5.5% increase compared to 2021. An interim dividend of €1.37 per ordinary share will be made payable on February 15, 2023.

Recognizing this interim dividend and the two interim dividends of €1.37 per ordinary share paid in 2022, this leads to a final dividend proposal to the General Meeting of €1.69 per ordinary share.

Details of the share buyback program as well as transactions pursuant thereto, and details of the dividend proposal are published on ASML's website (www.asml.com/investors).

---

| | |
|:---|:---|
| **Media Relations contacts** | **Investor Relations contacts** |
| Monique Mols +31 6 5284 4418 | Skip Miller +1 480 235 0934 |
| Ryan Young +1 480 205 8659  | Marcel Kemp +31 40 268 6494 |
| Karen Lo +886 939788635 | Peter Cheang +886 3 659 6771 |

---

**Quarterly video interview, investor call and annual press conference**

With this press release, ASML has published a video interview in which CEO Peter Wennink discusses the 2022 fourth-quarter and full-year results and outlook for 2023. This video and the transcript can be viewed on www.asml.com.

CEO Peter Wennink and CFO Roger Dassen will host a press conference in Veldhoven on January 25, 2023, at 11:00 Central European Time, which will also be accessible via a live webcast on www.asml.com.

An investor call for both investors and the media will be hosted by CEO Peter Wennink and CFO Roger Dassen on January 25, 2023 at 15:00 Central European Time / 09:00 US Eastern Time. Details can be found on our website.

**About ASML** 

ASML is a leading supplier to the semiconductor industry. The company provides chipmakers with hardware, software and services to mass produce the patterns of integrated circuits (microchips). Together with its partners, ASML drives the advancement of more affordable, more powerful, more energy-efficient microchips. ASML enables groundbreaking technology to solve some of humanity's toughest challenges, such as in healthcare, energy use and conservation, mobility and agriculture. ASML is a multinational company headquartered in Veldhoven, the Netherlands, with offices across Europe, the US and Asia. Every day, ASML's more than 39,000 employees (FTE) challenge the status quo and push technology to new limits. ASML is traded on Euronext Amsterdam and NASDAQ under the symbol ASML. Discover ASML – our products, technology and career opportunities – at www.asml.com.

**US GAAP and IFRS Financial Reporting** 

ASML's primary accounting standard for quarterly earnings releases and annual reports is US GAAP, the accounting principles generally accepted in the United States of America. Quarterly US GAAP consolidated statements of operations, consolidated statements of cash flows and consolidated balance sheets are available on www.asml.com.

The consolidated balance sheets of ASML Holding N.V. as of December 31, 2022, the related consolidated statements of operations and consolidated statements of cash flows for the quarter and twelve months ended December 31, 2022 as presented in this press release are unaudited.

------

In addition to reporting financial figures in accordance with US GAAP, ASML also reports financial figures in accordance with International Financial Reporting Standards as adopted by the European Union ('IFRS') for statutory purposes. The most significant recurring differences between US GAAP and IFRS that affect ASML concerns the capitalization of certain product development costs and accounting for income taxes.

**2022 Annual Reports**

ASML will publish its 2022 Annual Report based on US GAAP and its 2022 Annual Report based on IFRS on February 15, 2023. The reports will be published on our website, www.asml.com.

**Regulated information**

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

------

**Forward Looking Statements**

This document and related discussions contain statements that are forward-looking within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements with respect to plans, strategies, expected trends, including trends in semiconductor end markets and technology industry and business environment trends, statements with respect to demand and capacity, plans to increase capacity and capacity goals, outlook, backlog, bookings and orders, expected financial results, including expected net sales, gross margin, R&D costs, SG&A costs and estimated annualized effective tax rate for Q1 and full year 2023, expected shipments in 2023 including expected shipments of EUV and DUV systems, expected growth in EUV, non-EUV and IBM sales in 2023, statements made at our 2022 Investor Day including revenue and gross margin opportunity for 2025 and 2030, statements with respect to fast shipments including estimates of amounts of deferred revenue not yet recognized and expected timing of recognition of such deferred revenue for fast shipments, including deferred revenue from fast shipments in 2022 expected to be recognized in 2023, expected customer demand trends including expected rebound in second half of the year, statements about the market and macroeconomic trends including global megatrends, long-term growth opportunity, statements with respect to the geopolitical situation and export control policy and restrictions, statements with respect to capital allocation policy including plans to return significant amounts of cash thought growing dividends and buybacks and statements with respect to the Q4 interim and final 2022 dividend and statements with respect to share buyback programs, aim to improve ESG sustainability KPIs and upgrade ESG sustainability strategy and other non-historical statements. You can generally identify these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue", "target", "future", "progress", "goal" and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve a number of substantial known and unknown risks and uncertainties. These risks and uncertainties include, without limitation, economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors, trends in the semi-conductor industry, the impact of general economic conditions including the impact of the current macroeconomic uncertainty in the market and in consumer confidence, inflation, rising interest rates, geopolitical developments, the risk of a recession, demand for our customers' products, performance of our systems, the impact of the COVID-19 outbreak and measures taken to contain it on us, our suppliers, the global economy and financial markets, the impact of the Russian military actions in the Ukraine and measures taken in response on the global economy and global financial markets and other factors that may impact ASML's financial results, including customer demand and ASML's ability to obtain parts and components for its products and otherwise meet demand, the success of technology advances and the pace of new product development and customer acceptance of and demand for new products, production capacity and our ability to increase capacity to meet demand, the impact of inflation, the number and timing of systems ordered, shipped and recognized in revenue, and the risk of order cancellation or push out, supply chain capacity and constraints and logistics and constraints on our ability to produce systems to meet demand, the timing of recognition of deferred revenue from fast shipments and impact on our results, the impact of the gas shortage on us and our suppliers, our ability to enforce patents and protect intellectual property rights and the outcome of intellectual property disputes and litigation, availability of raw materials, critical manufacturing equipment and qualified employees, trade environment, import/export and national security regulations and orders and their impact on us including the impact of the recently updated US export regulations, changes in exchange and tax rates, available liquidity and liquidity requirements, our ability to refinance our indebtedness, available cash and distributable reserves for, and other factors impacting, dividend payments and share repurchases, results of the share repurchase programs, our ability to meet ESG goals and improve ESG KPIs and upgrade ESG strategy and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F for the year ended December 31, 2021 and other filings with and submissions to the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We undertake no obligation to update any forward-looking statements after the date of this report or to conform such statements to actual results or revised expectations, except as required by law.

## Exhibit 99.2

![](presentationinvestorrela001.jpg)

Public ASML 2022 Fourth-Quarter and Full-Year results Veldhoven, the Netherlands January 25, 2023 ASML reports €21.2 billion net sales and €5.6 billion net income in 2022 Despite challenging environment, continued strong sales growth expected in 2023 Exhibit 99.2

------

![](presentationinvestorrela002.jpg)

Public Page 2January 25, 2023 • Investor key messages • Business summary • Outlook • Financial statements Agenda

------

![](presentationinvestorrela003.jpg)

Public Page 3January 25, 2023 Investor key messages

------

![](presentationinvestorrela004.jpg)

Public Page 4January 25, 2023 Investor key messages • Global megatrends in the electronics industry, supported by a highly profitable and fiercely innovative ecosystem, are expected to continue to fuel growth across the semiconductor market • Growth in semiconductor end markets and increasing lithography intensity are driving demand for our products and services • ASML's comprehensive product portfolio is aligned with our customers' roadmaps, delivering cost effective solutions in support of all applications from leading edge to mature nodes • Based on different market scenarios1 as presented during our Investor Day in November 2022, we modeled an opportunity to reach annual revenue in 2025 between approximately €30 billion and €40 billion, with a gross margin between approximately 54% and 56% and in 2030 an annual revenue between approximately €44 billion and €60 billion, with a gross margin between approximately 56% and 60% • ASML and its supply chain partners are actively adding and improving capacity to meet current and future customer demand • We are continuously striving to improve our performance on ESG Sustainability and are upgrading our ESG Sustainability strategy to accelerate progress • We expect to continue to return significant amounts of cash to our shareholders through a combination of growing dividends and share buybacks 1 based on third party research and our assumptions

------

![](presentationinvestorrela005.jpg)

Public Page 5January 25, 2023 Business summary

------

![](presentationinvestorrela006.jpg)

Public Page 6January 25, 2023 2022 - Highlights ASML achieved a sales growth of 14%, reflecting the continued strong global demand for our products: • Net sales grew to €21.2 billion at 50.5% gross margin • Net income at €5.6 billion resulted in an EPS of €14.14 EUV lithography: • EUV system sales grew 12% to €7.0 billion, recognized 40 systems and shipped 54 • All five EUV customers have placed High-NA orders DUV lithography: • DUV system sales grew 13% to €7.7 billion, as part of our continued capacity ramp • Shipped new models on both ArF immersion (NXT:2100i) and dry (NXT:870) systems Applications: • Our Metrology & Inspection systems sales grew 28% to €660 million • Shipped our new eScan 460, eP5 XLE and eP6 e-beam systems Installed Base1: • Our Installed Base business grew 16% to €5.7 billion providing our customers services and upgrade capabilities Capital return: • Returned €7.2 billion to shareholders through dividends and share buybacks 1 Installed Base Management equals our net service and field option sales

------

![](presentationinvestorrela007.jpg)

Public Page 7January 25, 2023 1 Installed Base Management equals our net service and field option sales 2 Income from operations as a percentage of Total net sales 3 Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted. Q4 results summary • Net sales of €6.4 billion, net system sales of €4.7 billion, Installed Base Management1 sales of €1.7 billion • Gross margin of 51.5% • Operating margin2 of 33.0% • Net income as a percentage of net sales of 28.2% • Earnings per share (basic) of €4.60 • Net bookings3 of €6.3 billion ◦ including EUV bookings of €3.4 billion

------

![](presentationinvestorrela008.jpg)

Public Page 8January 25, 2023 Net system sales breakdown (Quarterly) Q4'22 Net system sales €4,748 million Q3'22 Net system sales €4,255 million

------

![](presentationinvestorrela009.jpg)

Public Page 9January 25, 2023 2022 Net system sales €15,430 million 2021 Net system sales €13,653 million Net system sales breakdown (Yearly)

------

![](presentationinvestorrela010.jpg)

Public Page 10January 25, 2023 Logic Memory Installed Base Management1 1 Installed Base Management equals our net service and field option sales Total net sales € million by End-use

------

![](presentationinvestorrela011.jpg)

Public Page 11January 25, 2023 Net systems bookings activity by End-use Q4'22 net system sales value €6,316 million Q3'22 net system sales value €8,920 million Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.

------

![](presentationinvestorrela012.jpg)

Public Page 12January 25, 2023 • ASML intends to declare a total dividend for the year 2022 of €5.80 per ordinary share. An interim dividend of €1.37 per ordinary share will be made payable on February 15, 2023 • Recognizing this (third) interim dividend and the two interim dividends of €1.37 per ordinary share paid in 2022, this leads to a final dividend proposal to the General Meeting of €1.69 per ordinary share • In Q4 2022 we purchased around 0.6 million shares for a total amount of around €300 million Capital return to shareholders Share buyback Dividend paid Third interim and final dividend for a year are paid in the subsequent year Total dividend Interim dividend Proposed final dividend Interim dividend (to be paid)

------

![](presentationinvestorrela013.jpg)

Public Page 13January 25, 2023 Outlook

------

![](presentationinvestorrela014.jpg)

Public Page 14January 25, 2023 Outlook Q1 • Net sales between €6.1 billion and €6.5 billion, including ◦ Installed Base Management1 sales of around €1.5 billion • Gross margin between 49% and 50% • R&D costs of around €965 million • SG&A costs of around €285 million 2023 • Expected net sales growth of more than 25% with a slight improvement in gross margin, relative to 2022 • Estimated annualized effective tax rate between 15% and 16% 1 Installed Base Management equals our net service and field option sales

------

![](presentationinvestorrela015.jpg)

Public Page 15January 25, 2023 Financial Statements

------

![](presentationinvestorrela016.jpg)

Public Page 16January 25, 2023 2018 2019 2020 2021 2022 Net sales 10,944 11,820 13,979 18,611 21,173 Gross profit 5,029 5,280 6,798 9,809 10,700 Gross margin % 46.0 44.7 48.6 52.7 50.5 Other income 1 — — — 214 — R&D costs (1,576) (1,968) (2,201) (2,547) (3,254) SG&A costs (488) (521) (545) (726) (946) Income from operations 2,965 2,791 4,051 6,750 6,501 Operating income as a % of net sales 27.1 23.6 29.0 36.3 30.7 Net income 2,592 2,592 3,554 5,883 5,624 Net income as a % of net sales 23.7 21.9 25.4 31.6 26.6 Earnings per share (basic) € 6.10 6.16 8.49 14.36 14.14 Earnings per share (diluted) € 6.08 6.15 8.48 14.34 14.13 Lithography systems sold (units) 2 224 229 258 309 345 Net bookings 3 8,181 11,740 11,292 26,240 30,674 These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience. Consolidated statements of operations € million Year on Year 1 Other income includes the gain on the sale of Berliner Glas subsidiaries 2 Lithography systems do not include metrology and inspection systems 3 Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.. Our 2018 and 2019 systems net bookings include 1 EUV and 1 DUV order shipped to our collaborative Research Center (Imec). These systems were not recognized in revenue.

------

![](presentationinvestorrela017.jpg)

Public Page 17January 25, 2023 Consolidated statements of operations € million Quarter on Quarter Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Net sales 4,986 3,534 5,431 5,778 6,430 Gross profit 2,701 1,731 2,665 2,994 3,311 Gross margin % 54.2 49.0 49.1 51.8 51.5 Other income 1 214 — — — — R&D costs (681) (739) (789) (819) (906) SG&A costs (203) (208) (222) (236) (280) Income from operations 2,031 784 1,653 1,939 2,125 Operating income as a % of net sales 40.7 22.2 30.4 33.5 33.0 Net income 1,774 695 1,411 1,701 1,817 Net income as a % of net sales 35.6 19.7 26.0 29.4 28.2 Earnings per share (basic) € 4.39 1.73 3.54 4.29 4.60 Earnings per share (diluted) € 4.38 1.73 3.54 4.29 4.60 Lithography systems sold (units) 2 82 62 91 86 106 Net bookings 3 7,050 6,977 8,461 8,920 6,316 1 Other income includes the gain on the sale of Berliner Glas subsidiaries 2 Lithography systems do not include metrology and inspection systems 3 Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted. These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.

------

![](presentationinvestorrela018.jpg)

Public Page 18January 25, 2023 2018 2019 2020 2021 2022 Cash and cash equivalents, beginning of period 2,259 3,121 3,532 6,049 6,952 Net cash provided by (used in) operating activities 3,073 3,276 4,628 10,847 8,487 Net cash provided by (used in) investing activities (492) (1,158) (1,352) (72) (1,029) Net cash provided by (used in) financing activities (1,724) (1,712) (753) (9,892) (7,138) Effect of changes in exchange rates on cash 5 5 (5) 20 (4) Net increase (decrease) in cash and cash equivalents 862 411 2,517 903 316 Cash and cash equivalents, end of period 3,121 3,532 6,049 6,952 7,268 Short-term investments 913 1,186 1,302 638 108 Cash and cash equivalents and short-term investments 4,034 4,718 7,351 7,590 7,376 Purchases of property, plant and equipment and intangible assets (610) (885) (1,001) (940) (1,319) Free cash flow 1 2,463 2,391 3,627 9,906 7,168 1 Free cash flow, which is a non-GAAP measure, is defined as net cash provided by (used in) operating activities minus purchases of Property, plant and equipment and intangible assets, see US GAAP Consolidated Financial Statements These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience. Consolidated statements of cash flows € million Year on Year

------

![](presentationinvestorrela019.jpg)

Public Page 19January 25, 2023 Consolidated statements of cash flows € million Quarter on Quarter Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Cash and cash equivalents, beginning of period 4,319 6,952 4,324 4,097 3,153 Net cash provided by (used in) operating activities 6,417 (586) 2,553 1,170 5,351 Net cash provided by (used in) investing activities (476) (12) (144) (509) (364) Net cash provided by (used in) financing activities (3,327) (2,030) (2,638) (1,613) (859) Effect of changes in exchange rates on cash 19 — 1 8 (13) Net increase (decrease) in cash and cash equivalents 2,633 (2,628) (228) (944) 4,115 Cash and cash equivalents, end of period 6,952 4,324 4,097 3,153 7,268 Short-term investments 638 399 305 210 108 Cash and cash equivalents and short-term investments 7,590 4,723 4,402 3,363 7,376 Purchases of property, plant and equipment and intangible assets (291) (252) (238) (364) (466) Free cash flow 1 6,126 (838) 2,315 805 4,885 1 Free cash flow, which is a non-GAAP measure, is defined as net cash provided by (used in) operating activities minus purchases of Property, plant and equipment and intangible assets, see US GAAP Consolidated Financial Statements These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.

------

![](presentationinvestorrela020.jpg)

Public Page 20January 25, 2023 Assets 2018 2019 2020 2021 2022 Cash & cash equivalents and short-term investments 4,034 4,718 7,352 7,590 7,376 Net accounts receivable and finance receivables 2,384 2,773 3,421 4,597 6,680 Contract assets 96 231 119 165 132 Inventories, net 3,440 3,809 4,569 5,179 7,200 Loan receivable1 — — — 124 364 Other assets 1,579 1,673 1,753 1,886 2,383 Tax assets 316 624 739 1,141 1,706 Equity method investments 916 833 821 893 924 Goodwill 4,541 4,541 4,629 4,556 4,556 Other intangible assets 1,104 1,105 1,049 952 842 Property, plant and equipment 1,589 1,999 2,470 2,983 3,944 Right-of-use assets 138 324 345 165 193 Total assets 20,137 22,630 27,267 30,231 36,300 Liabilities and shareholders' equity Current liabilities 3,792 4,694 6,604 12,298 17,983 Non-current liabilities 4,704 5,344 6,798 7,792 9,506 Shareholders' equity 11,641 12,592 13,865 10,141 8,811 Total liabilities and shareholders' equity 20,137 22,630 27,267 30,231 36,300 These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience. 1. Loan receivable for 2021 was previously reported as part of Other assets Consolidated balance sheets € million Year on Year

------

![](presentationinvestorrela021.jpg)

Public Page 21January 25, 2023 Consolidated balance sheets € million Quarter on Quarter Assets Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Cash & cash equivalents and short-term investments 7,590 4,723 4,402 3,363 7,376 Net accounts receivable and finance receivables 4,597 4,954 6,610 7,414 6,680 Contract assets 165 371 270 277 132 Inventories, net 5,179 6,074 6,367 6,884 7,200 Loan receivable 124 124 124 364 364 Other assets 1,886 2,278 2,282 2,403 2,383 Tax assets 1,141 1,953 1,899 1,905 1,706 Equity method investments 893 940 961 999 924 Goodwill 4,556 4,556 4,556 4,556 4,556 Other intangible assets 952 923 896 870 842 Property, plant and equipment 2,983 3,159 3,358 3,562 3,944 Right-of-use assets 165 177 188 207 193 Total assets 30,231 30,232 31,913 32,804 36,300 Liabilities and shareholders' equity Current liabilities 12,298 13,613 14,637 15,669 17,983 Non-current liabilities 7,792 7,809 9,627 9,180 9,506 Shareholders' equity 10,141 8,810 7,649 7,955 8,811 Total liabilities and shareholders' equity 30,231 30,232 31,913 32,804 36,300 These numbers have been prepared in accordance with US GAAP. Numbers have been rounded for readers' convenience.

------

![](presentationinvestorrela022.jpg)

Public Page 22January 25, 2023 This document and related discussions contain statements that are forward-looking within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements with respect to plans, strategies, expected trends, including trends in semiconductor end markets and technology industry and business environment trends, statements with respect to demand and capacity, plans to increase capacity and capacity goals, outlook, backlog, bookings and orders, expected financial results, including expected net sales, gross margin, R&D costs, SG&A costs and estimated annualized effective tax rate for Q1 and full year 2023, expected shipments in 2023 including expected shipments of EUV and DUV systems, expected growth in EUV, non-EUV and IBM sales in 2023, statements made at our 2022 Investor Day including revenue and gross margin opportunity for 2025 and 2030, statements with respect to fast shipments including estimates of amounts of deferred revenue not yet recognized and expected timing of recognition of such deferred revenue for fast shipments, including deferred revenue from fast shipments in 2022 expected to be recognized in 2023, expected customer demand trends including expected rebound in second half of the year, statements about the market and macroeconomic trends including global megatrends, long-term growth opportunity, statements with respect to the geopolitical situation and export control policy and restrictions, statements with respect to capital allocation policy including plans to return significant amounts of cash thought growing dividends and buybacks and statements with respect to the Q4 interim and final 2022 dividend and statements with respect to share buyback programs, aim to improve ESG sustainability KPIs and upgrade ESG sustainability strategy and other non-historical statements. You can generally identify these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue", "target", "future", "progress", "goal" and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve a number of substantial known and unknown risks and uncertainties. These risks and uncertainties include, without limitation, economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors, trends in the semi-conductor industry, the impact of general economic conditions including the impact of the current macroeconomic uncertainty in the market and in consumer confidence, inflation, rising interest rates, geopolitical developments, the risk of a recession, demand for our customers' products, performance of our systems, the impact of the COVID-19 outbreak and measures taken to contain it on us, our suppliers, the global economy and financial markets, the impact of the Russian military actions in the Ukraine and measures taken in response on the global economy and global financial markets and other factors that may impact ASML's financ ial results, including customer demand and ASML's ability to obtain parts and components for its products and otherwise meet demand, the success of technology advances and the pace of new product development and customer acceptance of and demand for new products, production capacity and our ability to increase capacity to meet demand, the impact of inflation, the number and timing of systems ordered, shipped and recognized in revenue, and the risk of order cancellation or push out, supply chain capacity and constraints and logistics and constraints on our ability to produce systems to meet demand, the timing of recognition of deferred revenue from fast shipments and impact on our results, the impact of the gas shortage on us and our suppliers, our ability to enforce patents and protect intellectual property rights and the outcome of intellectual property disputes and litigation, availability of raw materials, critical manufacturing equipment and qualified employees, trade environment, import/export and national security regulations and orders and their impact on us including the impact of the recently updated US export regulations, changes in exchange and tax rates, available liquidity and liquidity requirements, our ability to refinance our indebtedness, available cash and distributable reserves for, and other factors impacting, dividend payments and share repurchases, results of the share repurchase programs, our ability to meet ESG goals and improve ESG KPIs and upgrade ESG strategy and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F for the year ended December 31, 2021 and other filings with and submissions to the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We undertake no obligation to update any forward-looking statements after the date of this report or to conform such statements to actual results or revised expectations, except as required by law. Forward looking statements

------

![](presentationinvestorrela023.jpg)

Public Page 23January 25, 2023 1 Net Deferred Revenue: Net delayed revenue recognition into subsequent quarters due to Fast Shipments shipped in the relevant quarter or year 2 Fast Shipment: A fast shipment process skips some of the testing in our factory. Final testing and formal acceptance then takes place at the customer site. This leads to a deferral of revenue recognition for those shipments until formal customer acceptance but does provide our customers with earlier access to wafer output capacity 3 Normalized Revenue, which is a non-GAAP measure, is defined as Total Net Sales plus Net Deferred Revenue from Fast Shipments, see US GAAP Consolidated Financial Statements (as published on www.asml.com) Appendix Reconciliation Normalized Revenue (as included in the Interview with Peter Wennink and related Video Transcript) Q1 2022 Q2 2022 Q3 2022 Q4 2022 FY 2022 Total Net Sales €3.5 billion €5.4 billion €5.8 billion €6.4 billion €21.2 billion Net Deferred Revenue1 from Fast Shipment2 €1.4 billion €0.3 billion €0.2 billion €1.0 billion €2.8 billion Normalized Revenue3 €4.9 billion €5.7 billion €6.0 billion €7.4 billion €24.0 billion

------

![](presentationinvestorrela024.jpg)

Public

------

## Exhibit 99.3

**Exhibit 99.3**

**ASML - Summary US GAAP Consolidated Statements of Operations**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three months ended, | Three months ended, | Twelve months ended, | Twelve months ended, |
| | Dec 31, | Dec 31, | Dec 31, | Dec 31, |
| (unaudited, in millions €, except per share data) | 2021 | 2022 | 2021 | 2022 |
| Net system sales | 3463.2 | 4747.9 | 13652.8 | 15430.3 |
| Net service and field option sales | 1522.4 | 1682.3 | 4958.2 | 5743.1 |
| Total net sales | 4985.6 | 6430.2 | 18611.0 | 21173.4 |
| Total cost of sales | (2285.0) | (3119.3) | (8802.0) | (10473.3) |
| Gross profit | 2700.6 | 3310.9 | 9809.0 | 10700.1 |
| Research and development costs | (680.6) | (906.3) | (2547.0) | (3253.5) |
| Selling, general and administrative costs | (202.5) | (280.4) | (725.6) | (945.9) |
| Other income <sup>1</sup> | 213.7 |  | 213.7 |  |
| Income from operations | 2031.2 | 2124.2 | 6750.1 | 6500.7 |
| Interest and other, net | (12.2) | (3.1) | (44.6) | (44.6) |
| Income before income taxes | 2019.0 | 2121.1 | 6705.5 | 6456.1 |
| Income tax expense | (316.0) | (357.3) | (1021.4) | (969.9) |
| Income after income taxes | 1703.0 | 1763.8 | 5684.1 | 5486.2 |
| Profit related to equity method investments | 70.4 | 52.7 | 199.1 | 138.0 |
| Net income | 1773.4 | 1816.5 | 5883.2 | 5624.2 |
| Basic net income per ordinary share | 4.39 | 4.60 | 14.36 | 14.14 |
| Diluted net income per ordinary share | 4.38 | 4.60 | 14.34 | 14.13 |
| *Weighted average number of ordinary shares used in computing per share amounts (in millions):* | *Weighted average number of ordinary shares used in computing per share amounts (in millions):* | *Weighted average number of ordinary shares used in computing per share amounts (in millions):* | *Weighted average number of ordinary shares used in computing per share amounts (in millions):* | *Weighted average number of ordinary shares used in computing per share amounts (in millions):* |
| Basic | 404.3 | 394.9 | 409.8 | 397.7 |
| Diluted | 405.0 | 395.2 | 410.4 | 398.1 |

---

**ASML - Ratios and Other Data**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three months ended, | Three months ended, | Twelve months ended, | Twelve months ended, |
| | Dec 31, | Dec 31, | Dec 31, | Dec 31, |
| (unaudited, in millions €, except otherwise indicated) | 2021 | 2022 | 2021 | 2022 |
| Gross profit as a percentage of net sales | 54.2% | 51.5% | 52.7% | 50.5% |
| Income from operations as a percentage of net sales | 40.7% | 33.0% | 36.3% | 30.7% |
| Net income as a percentage of net sales | 35.6% | 28.2% | 31.6% | 26.6% |
| Income taxes as a percentage of income before income taxes | 15.7% | 16.8% | 15.2% | 15.0% |
| Shareholders' equity as a percentage of total assets | 33.5% | 24.3% | 33.5% | 24.3% |
| Sales of lithography systems (in units) <sup>2</sup> | 82 | 106 | 309 | 345 |
| Value of booked systems (EUR millions) <sup>3</sup> | 7050 | 6316 | 26240 | 30674 |
| Net bookings lithography systems (in units) <sup>2, 3</sup> | 191 | 101 | 656 | 553 |
| Number of payroll employees in FTEs | 29861 | 36112 | 29861 | 36112 |
| Number of temporary employees in FTEs | 2155 | 2974 | 2155 | 2974 |

---

1. Other income includes the gain on sale of Berliner Glas subsidiaries

2. Lithography systems do not include metrology and inspection systems

3. Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.

------

**ASML - Summary US GAAP Consolidated Balance Sheets**

---

| | | |
|:---|:---|:---|
| | Dec 31, | Dec 31, |
| (unaudited, in millions €) | 2021 | 2022 |
| **ASSETS** |  |  |
| Cash and cash equivalents | 6951.8 | 7268.3 |
| Short-term investments | 638.5 | 107.7 |
| Accounts receivable, net | 3028.0 | 5323.8 |
| Finance receivables, net | 1185.6 | 1356.7 |
| Current tax assets | 42.0 | 33.4 |
| Contract assets | 164.6 | 131.9 |
| Inventories, net | 5179.2 | 7199.7 |
| Other assets | 1000.5 | 1643.4 |
| Total current assets | 18190.2 | 23064.9 |
| Finance receivables, net | 383.0 |  |
| Deferred tax assets | 1098.7 | 1672.8 |
| Loan receivable | 124.4 | 364.4 |
| Other assets | 887.0 | 739.8 |
| Equity method investments | 892.5 | 923.6 |
| Goodwill | 4555.6 | 4555.6 |
| Other intangible assets, net | 952.1 | 842.4 |
| Property, plant and equipment, net | 2982.7 | 3944.2 |
| Right-of-use assets | 164.8 | 192.7 |
| Total non-current assets | 12040.8 | 13235.5 |
| Total assets | 30231.0 | 36300.4 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
| Current liabilities | 12298.0 | 17983.6 |
| Total current liabilities | 12298.0 | 17983.6 |
| Long-term debt | 4075.0 | 3514.2 |
| Deferred and other tax liabilities | 240.6 | 267.0 |
| Contract liabilities | 3225.7 | 5269.9 |
| Accrued and other liabilities | 251.1 | 454.9 |
| Total non-current liabilities | 7792.4 | 9506.0 |
| Total liabilities | 20090.4 | 27489.6 |
| Total shareholders' equity | 10140.6 | 8810.8 |
| Total liabilities and shareholders' equity | 30231.0 | 36300.4 |

---

------

**ASML - Summary US GAAP Consolidated Statements of Cash Flows**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three months ended, | Three months ended, | Twelve months ended, | Twelve months ended, |
| | Dec 31, | Dec 31, | Dec 31, | Dec 31, |
| (unaudited, in millions €) | 2021 | 2022 | 2021 | 2022 |
| **CASH FLOWS FROM OPERATING ACTIVITIES** |  |  |  |  |
| Net income | 1773.4 | 1816.5 | 5883.2 | 5624.2 |
| Adjustments to reconcile net income to net cash flows from operating activities: |  |  |  |  |
| Depreciation and amortization | 124.2 | 183.2 | 471.0 | 583.6 |
| Impairment and loss (gain) on disposal | 17.5 | 13.7 | (15.9) | 39.3 |
| Share-based compensation expense | 33.5 | 21.0 | 117.5 | 68.9 |
| Gain on sale of subsidiaries | (213.7) |  | (213.7) |  |
| Inventory reserves | 49.4 | 71.3 | 180.7 | 278.5 |
| Deferred tax expense (benefit) | (106.2) | (89.0) | (419.6) | (564.2) |
| Equity method investments | 91.4 | 120.8 | (49.8) | 15.3 |
| Changes in assets and liabilities | 4647.5 | 3213.0 | 4892.4 | 2441.2 |
| Net cash provided by (used in) operating activities | 6417.0 | 5350.5 | 10845.8 | 8486.8 |
| **CASH FLOWS FROM INVESTING ACTIVITIES** |  |  |  |  |
| Purchase of property, plant and equipment | (273.2) | (453.6) | (900.7) | (1281.8) |
| Purchase of intangible assets | (17.5) | (12.3) | (39.6) | (37.5) |
| Purchase of short-term investments | (504.2) | (4.2) | (1162.7) | (334.3) |
| Maturity of short-term investments | 2.7 | 106.1 | 1826.4 | 864.7 |
| Loans issued and other investments |  |  | (124.4) | (240.0) |
| Proceeds from sale of subsidiaries (net of cash disposed) | 316.1 |  | 329.0 |  |
| Net cash provided by (used in) investing activities | (476.1) | (364.0) | (72.0) | (1028.9) |
| **CASH FLOWS FROM FINANCING ACTIVITIES** |  |  |  |  |
| Dividend paid | (729.2) | (541.1) | (1368.3) | (2559.8) |
| Purchase of treasury shares | (2607.2) | (335.0) | (8560.3) | (4639.7) |
| Net proceeds from issuance of shares | 12.0 | 18.9 | 48.9 | 81.8 |
| Net proceeds from issuance of notes, net of issuance costs |  |  |  | 495.6 |
| Repayment of debt and finance lease obligations | (2.6) | (0.8) | (12.0) | (516.2) |
| Net cash provided by (used in) financing activities | (3327.0) | (858.0) | (9891.7) | (7138.3) |
| Net cash flows | 2613.9 | 4128.5 | 882.1 | 319.6 |
| Effect of changes in exchange rates on cash | 19.2 | (13.0) | 20.3 | (3.1) |
| Net increase (decrease) in cash and cash equivalents | 2633.1 | 4115.5 | 902.4 | 316.5 |
| Cash and cash equivalents at beginning of the period | 4318.7 | 3152.8 | 6049.4 | 6951.8 |
| Cash and cash equivalents at end of the period | 6951.8 | 7268.3 | 6951.8 | 7268.3 |

---

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**ASML - Quarterly Summary US GAAP Consolidated Statements of Operations**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Three months ended, | Three months ended, | Three months ended, | Three months ended, | Three months ended, |
| | Dec 31, | Apr 3, | Jul 3, | Oct 2, | Dec 31, |
| (unaudited, in millions €, except per share data) | 2021 | 2022 | 2022 | 2022 | 2022 |
| Net system sales | 3463.2 | 2287.2 | 4140.5 | 4254.7 | 4747.9 |
| Net service and field option sales | 1522.4 | 1247.2 | 1290.0 | 1523.6 | 1682.3 |
| Total net sales | 4985.6 | 3534.4 | 5430.5 | 5778.3 | 6430.2 |
| Total cost of sales | (2285.0) | (1803.4) | (2766.0) | (2784.6) | (3119.3) |
| Gross profit | 2700.6 | 1731.0 | 2664.5 | 2993.7 | 3310.9 |
| Research and development costs | (680.6) | (738.7) | (789.1) | (819.4) | (906.3) |
| Selling, general and administrative costs | (202.5) | (207.7) | (222.0) | (235.8) | (280.4) |
| Other income <sup>1</sup> | 213.7 |  |  |  |  |
| Income from operations | 2031.2 | 784.6 | 1653.4 | 1938.5 | 2124.2 |
| Interest and other, net | (12.2) | (15.6) | (10.8) | (15.1) | (3.1) |
| Income before income taxes | 2019.0 | 769.0 | 1642.6 | 1923.4 | 2121.1 |
| Benefit from (provision for) income taxes | (316.0) | (114.4) | (246.2) | (252.0) | (357.3) |
| Income after income taxes | 1703.0 | 654.6 | 1396.4 | 1671.4 | 1763.8 |
| Profit related to equity method investments | 70.4 | 40.7 | 14.5 | 30.1 | 52.7 |
| Net income | 1773.4 | 695.3 | 1410.9 | 1701.5 | 1816.5 |
| Basic net income per ordinary share | 4.39 | 1.73 | 3.54 | 4.29 | 4.60 |
| Diluted net income per ordinary share | 4.38 | 1.73 | 3.54 | 4.29 | 4.60 |
| *Weighted average number of ordinary shares used in computing per share amounts (in millions):* | *Weighted average number of ordinary shares used in computing per share amounts (in millions):* | *Weighted average number of ordinary shares used in computing per share amounts (in millions):* | *Weighted average number of ordinary shares used in computing per share amounts (in millions):* |  |  |
| Basic | 404.3 | 401.1 | 398.3 | 396.2 | 394.9 |
| Diluted | 405.0 | 401.5 | 398.6 | 396.6 | 395.2 |

---

**ASML - Quarterly Summary Ratios and other data**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Dec 31, | Apr 3, | Jul 3, | Oct 2, | Dec 31, |
| (unaudited, in millions €, except otherwise indicated) | 2021 | 2022 | 2022 | 2022 | 2022 |
| Gross profit as a percentage of net sales | 54.2% | 49.0% | 49.1% | 51.8% | 51.5% |
| Income from operations as a percentage of net sales | 40.7% | 22.2% | 30.4% | 33.5% | 33.0% |
| Net income as a percentage of net sales | 35.6% | 19.7% | 26.0% | 29.4% | 28.2% |
| Income taxes as a percentage of income before income taxes | 15.7% | 14.9% | 15.0% | 13.1% | 16.8% |
| Shareholders' equity as a percentage of total assets | 33.5% | 29.1% | 24.0% | 24.3% | 24.3% |
| Sales of lithography systems (in units) <sup>2</sup> | 82 | 62 | 91 | 86 | 106 |
| Value of booked systems (EUR millions) <sup>3</sup> | 7050 | 6977 | 8461 | 8920 | 6316 |
| Net bookings lithography systems (in units) <sup>2, 3</sup> | 191 | 163 | 139 | 150 | 101 |
| Number of payroll employees in FTEs  | 29861 | 30861 | 32627 | 34720 | 36112 |
| Number of temporary employees in FTEs | 2155 | 2329 | 2689 | 2875 | 2974 |

---

1. Other income includes the gain on sale of Berliner Glas subsidiaries&nbsp;&nbsp;&nbsp;&nbsp;

2. Lithography systems do not include metrology and inspection systems

3. Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.

------

**ASML - Quarterly Summary US GAAP Consolidated Balance Sheets**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Dec 31, | Apr 3, | Jul 3, | Oct 2, | Dec 31, |
| (unaudited, in millions €) | 2021 | 2022 | 2022 | 2022 | 2022 |
| **ASSETS** |  |  |  |  |  |
| Cash and cash equivalents | 6951.8 | 4324.1 | 4096.5 | 3152.8 | 7268.3 |
| Short-term investments | 638.5 | 398.5 | 305.4 | 210.0 | 107.7 |
| Accounts receivable, net | 3028.0 | 3494.6 | 5376.7 | 5840.2 | 5323.8 |
| Finance receivables, net | 1185.6 | 1267.6 | 1233.1 | 1399.4 | 1356.7 |
| Current tax assets | 42.0 | 811.0 | 658.0 | 305.6 | 33.4 |
| Contract assets | 164.6 | 371.3 | 270.4 | 276.9 | 131.9 |
| Inventories, net | 5179.2 | 6073.5 | 6367.1 | 6884.0 | 7199.7 |
| Other assets | 1000.5 | 1468.2 | 1528.1 | 1657.5 | 1643.4 |
| Total current assets | 18190.2 | 18208.8 | 19835.3 | 19726.4 | 23064.9 |
| Finance receivables, net | 383.0 | 191.5 |  | 174.9 |  |
| Deferred tax assets | 1098.7 | 1141.9 | 1240.8 | 1599.6 | 1672.8 |
| Loan receivable | 124.4 | 124.4 | 124.4 | 364.4 | 364.4 |
| Other assets | 887.0 | 809.8 | 752.9 | 745.2 | 739.8 |
| Equity method investments | 892.5 | 940.0 | 961.4 | 998.7 | 923.6 |
| Goodwill | 4555.6 | 4555.6 | 4555.6 | 4555.6 | 4555.6 |
| Other intangible assets, net | 952.1 | 923.4 | 896.1 | 870.1 | 842.4 |
| Property, plant and equipment, net | 2982.7 | 3159.4 | 3357.7 | 3561.7 | 3944.2 |
| Right-of-use assets | 164.8 | 177.1 | 188.4 | 206.9 | 192.7 |
| Total non-current assets | 12040.8 | 12023.0 | 12077.3 | 13077.1 | 13235.5 |
| Total assets | 30231.0 | 30231.8 | 31912.6 | 32803.5 | 36300.4 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |  |  |  |
| Current liabilities | 12298.0 | 13612.8 | 14637.0 | 15668.6 | 17983.6 |
| Total current liabilities | 12298.0 | 13612.8 | 14637.0 | 15668.6 | 17983.6 |
| Long-term debt | 4075.0 | 3951.7 | 4385.3 | 3503.1 | 3514.2 |
| Deferred and other tax liabilities | 240.6 | 262.2 | 252.4 | 283.0 | 267.0 |
| Contract liabilities | 3225.7 | 3292.2 | 4630.6 | 4918.6 | 5269.9 |
| Accrued and other liabilities | 251.1 | 302.5 | 358.7 | 475.1 | 454.9 |
| Total non-current liabilities | 7792.4 | 7808.6 | 9627.0 | 9179.8 | 9506.0 |
| Total liabilities | 20090.4 | 21421.4 | 24264.0 | 24848.4 | 27489.6 |
| Total shareholders' equity | 10140.6 | 8810.4 | 7648.6 | 7955.1 | 8810.8 |
| Total liabilities and shareholders' equity | 30231.0 | 30231.8 | 31912.6 | 32803.5 | 36300.4 |

---

------

**ASML - Quarterly Summary US GAAP Consolidated Statements of Cash Flows**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Three months ended, | Three months ended, | Three months ended, | Three months ended, | Three months ended, |
| | Dec 31, | Apr 3, | Jul 3, | Oct 2, | Dec 31, |
| (unaudited, in millions €) | 2021 | 2022 | 2022 | 2022 | 2022 |
| **CASH FLOWS FROM OPERATING ACTIVITIES** |  |  |  |  |  |
| Net income | 1773.4 | 695.3 | 1410.9 | 1701.5 | 1816.5 |
| Adjustments to reconcile net income to net cash flows from operating activities: |  |  |  |  |  |
| Depreciation and amortization | 124.2 | 131.0 | 131.5 | 137.9 | 183.2 |
| Impairment and loss (gain) on disposal | 17.5 | 12.1 | 0.3 | 13.2 | 13.7 |
| Share-based compensation expense | 33.5 | 11.5 | 13.9 | 22.5 | 21.0 |
| Gain on sale of subsidiaries | (213.7) |  |  |  |  |
| Inventory reserves | 49.4 | 50.2 | 75.2 | 81.8 | 71.3 |
| Deferred tax expense (benefit) | (106.2) | (39.7) | (94.7) | (340.8) | (89.0) |
| Equity method investments | 91.4 | (47.5) | (21.2) | (36.8) | 120.8 |
| Changes in assets and liabilities | 4647.5 | (1399.0) | 1037.0 | (409.8) | 3213.0 |
| Net cash provided by (used in) operating activities | 6417.0 | (586.1) | 2552.9 | 1169.5 | 5350.5 |
| **CASH FLOWS FROM INVESTING ACTIVITIES** |  |  |  |  |  |
| Purchase of property, plant and equipment | (273.2) | (240.1) | (231.5) | (356.6) | (453.6) |
| Purchase of intangible assets | (17.5) | (11.5) | (6.0) | (7.7) | (12.3) |
| Purchase of short-term investments | (504.2) | (19.6) | (206.4) | (104.1) | (4.2) |
| Maturity of short-term investments | 2.7 | 259.5 | 299.6 | 199.5 | 106.1 |
| Loans issued and other investments |  |  |  | (240.0) |  |
| Proceeds from sale of subsidiaries (net of cash disposed) | 316.1 |  |  |  |  |
| Net cash provided by (used in) investing activities | (476.1) | (11.7) | (144.3) | (508.9) | (364.0) |
| **CASH FLOWS FROM FINANCING ACTIVITIES** |  |  |  |  |  |
| Dividend paid | (729.2) |  | (1475.3) | (543.5) | (541.1) |
| Purchase of treasury shares | (2607.2) | (2038.2) | (1178.5) | (1087.9) | (335.0) |
| Net proceeds from issuance of shares | 12.0 | 21.5 | 21.5 | 19.9 | 18.9 |
| Net proceeds from issuance of notes, net of issuance costs |  |  | 495.6 |  |  |
| Repayment of debt and finance lease obligations | (2.6) | (13.5) | (500.7) | (1.2) | (0.8) |
| Net cash provided by (used in) financing activities | (3327.0) | (2030.2) | (2637.4) | (1612.7) | (858.0) |
| Net cash flows | 2613.9 | (2628.0) | (228.8) | (952.1) | 4128.5 |
| Effect of changes in exchange rates on cash | 19.2 | 0.3 | 1.2 | 8.4 | (13.0) |
| Net increase (decrease) in cash and cash equivalents | 2633.1 | (2627.7) | (227.6) | (943.7) | 4115.5 |
| Cash and cash equivalents at beginning of the period | 4318.7 | 6951.8 | 4324.1 | 4096.5 | 3152.8 |
| Cash and cash equivalents at end of the period | 6951.8 | 4324.1 | 4096.5 | 3152.8 | 7268.3 |

---

------

**Notes to the Summary US GAAP Consolidated Financial Statements**

Basis of preparation

The accompanying unaudited Summary Consolidated Financial Statements have been prepared in conformity with the accounting principles generally accepted in the United States of America ("US GAAP").

For further details on our annual disclosure requirements under US GAAP, including our significant accounting policies, these interim unaudited Summary Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes included within our 2021 Annual Report based on US GAAP, which is available on www.asml.com.

------

Forward Looking Statements

This document and related discussions contain statements that are forward-looking within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements with respect to plans, strategies, expected trends, including trends in semiconductor end markets and technology industry and business environment trends, statements with respect to demand and capacity, plans to increase capacity and capacity goals, outlook, backlog, bookings and orders, expected financial results, including expected net sales, gross margin, R&D costs, SG&A costs and estimated annualized effective tax rate for Q1 and full year 2023, expected shipments in 2023 including expected shipments of EUV and DUV systems, expected growth in EUV, non-EUV and IBM sales in 2023, statements made at our 2022 Investor Day including revenue and gross margin opportunity for 2025 and 2030, statements with respect to fast shipments including estimates of amounts of deferred revenue not yet recognized and expected timing of recognition of such deferred revenue for fast shipments, including deferred revenue from fast shipments in 2022 expected to be recognized in 2023, expected customer demand trends including expected rebound in second half of the year, statements about the market and macroeconomic trends including global megatrends, long-term growth opportunity, statements with respect to the geopolitical situation and export control policy and restrictions, statements with respect to capital allocation policy including plans to return significant amounts of cash thought growing dividends and buybacks and statements with respect to the Q4 interim and final 2022 dividend and statements with respect to share buyback programs, aim to improve ESG sustainability KPIs and upgrade ESG sustainability strategy and other non-historical statements. You can generally identify these statements by the use of words like "may", "will", "could", "should", "project", "believe", "anticipate", "expect", "plan", "estimate", "forecast", "potential", "intend", "continue", "target", "future", "progress", "goal" and variations of these words or comparable words. These statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our business and our future financial results and readers should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve a number of substantial known and unknown risks and uncertainties. These risks and uncertainties include, without limitation, economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors, trends in the semi-conductor industry, the impact of general economic conditions including the impact of the current macroeconomic uncertainty in the market and in consumer confidence, inflation, rising interest rates, geopolitical developments, the risk of a recession, demand for our customers' products, performance of our systems, the impact of the COVID-19 outbreak and measures taken to contain it on us, our suppliers, the global economy and financial markets, the impact of the Russian military actions in the Ukraine and measures taken in response on the global economy and global financial markets and other factors that may impact ASML's financial results, including customer demand and ASML's ability to obtain parts and components for its products and otherwise meet demand, the success of technology advances and the pace of new product development and customer acceptance of and demand for new products, production capacity and our ability to increase capacity to meet demand, the impact of inflation, the number and timing of systems ordered, shipped and recognized in revenue, and the risk of order cancellation or push out, supply chain capacity and constraints and logistics and constraints on our ability to produce systems to meet demand, the timing of recognition of deferred revenue from fast shipments and impact on our results, the impact of the gas shortage on us and our suppliers, our ability to enforce patents and protect intellectual property rights and the outcome of intellectual property disputes and litigation, availability of raw materials, critical manufacturing equipment and qualified employees, trade environment, import/export and national security regulations and orders and their impact on us including the impact of the recently updated US export regulations, changes in exchange and tax rates, available liquidity and liquidity requirements, our ability to refinance our indebtedness, available cash and distributable reserves for, and other factors impacting, dividend payments and share repurchases, results of the share repurchase programs, our ability to meet ESG goals and improve ESG KPIs and upgrade ESG strategy and other risks indicated in the risk factors included in ASML's Annual Report on Form 20-F for the year ended December 31, 2021 and other filings with and submissions to the US Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We undertake no obligation to update any forward-looking statements after the date of this report or to conform such statements to actual results or revised expectations, except as required by law.

<br>